Early diagnosis through the use of in vitro diagnostics (IVDs) plays a critical role in patient outcomes and in supporting the healthcare system as a whole.
The UK government pledged in May to use artificial intelligence (AI) to prevent more than 20,000 cancer-related deaths a year by 2033, with the prime minister’s plans being welcomed by heal
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh